samrat-pharmachem-ltd
Home
Samrat Pharmachem Ltd
null Share Price
BSE:
NSE:
null Share Price
BSE:
NSE:
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹133.55 Cr
PE Ratio
20.65
Samrat Pharmachem Ltd Performance
▲
▲
▲
▲
Samrat Pharmachem Ltd Fundamentals
Samrat Pharmachem Ltd Delivery and Volume
About Samrat Pharmachem Ltd
Samrat Pharmachem Ltd was incorporated on June 16, 1992. The Company's principal activities are manufacturing and selling chemicals.
The Company floated a new 100% subsidiary company during the year 2003-04 named as Samrat Remedies Limited to carry on activities of Manufacturing of Pharmaceutical
| Name | Designation |
|---|---|
| Lalit Mehta | Chairman & Managing Director |
| Rajesh Mehta | Director & CFO |
| Mahendra Pipalia | Independent Director |
| Samir Kothary | Independent Director |
| Renu P Dharod | Independent Director |
| Megh Mehta | Executive Director |
| Nishant Kankaria | Company Sec. & Compli. Officer |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Samrat Pharmachem Ltd FAQs
How do I Buy Samrat Pharmachem Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Samrat Pharmachem Ltd shares in BlinkX.
What is the Share Price of Samrat Pharmachem Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Samrat Pharmachem Ltd's share price is ₹432.2 as of 2024-12-15.
What is the PE ratio of Samrat Pharmachem Ltd?
Samrat Pharmachem Ltd's P/E ratio is 20.65 times as of 2024-12-15.
What is the PB ratio of Samrat Pharmachem Ltd?
Samrat Pharmachem Ltd's most recent financial reports indicate a price-to-book ratio of 1.92, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Samrat Pharmachem Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Samrat Pharmachem Ltd's market capitalization is ₹133.55 Cr as on 2024-12-15.
What is the ROE of Samrat Pharmachem Ltd?
The current financial records of Samrat Pharmachem Ltd show a 3.37% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Samrat Pharmachem Ltd?
According to Samrat Pharmachem Ltd's most recent financial filings, the company has a total asset value of ₹103, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Samrat Pharmachem Ltd?
The 52-week high/low price of a Samrat Pharmachem Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Samrat Pharmachem Ltd's 52-week high and low as of 2024-12-15 are ₹439.5 and ₹403.8, respectively.
